651 related articles for article (PubMed ID: 28687357)
1. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.
Zhong Z; Huang M; Lv M; He Y; Duan C; Zhang L; Chen J
Cancer Lett; 2017 Sep; 403():305-317. PubMed ID: 28687357
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation.
Yang C; Li Q; Chen X; Zhang Z; Mou Z; Ye F; Jin S; Jun X; Tang F; Jiang H
Aging (Albany NY); 2020 Apr; 12(8):6865-6879. PubMed ID: 32305958
[TBL] [Abstract][Full Text] [Related]
3. CircFSCN1 induces tumor progression and triggers epithelial-mesenchymal transition in bladder cancer through augmentation of MDM2-mediated p53 silencing.
Deng W; Chen R; Xiong S; Nie J; Yang H; Jiang M; Hu B; Liu X; Fu B
Cell Signal; 2024 Feb; 114():110982. PubMed ID: 37981069
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis via VEGFA in upper tract urothelial carcinoma.
Wang CS; Lee YC; Jhan JH; Li WM; Chang LL; Huang AM; Lin HH; Wu YR; Hsu WC; Ke HL
J Gene Med; 2024 Jan; 26(1):e3616. PubMed ID: 38049938
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA).
Kasza Z; Fredlund Fuchs P; Tamm C; Eriksson AS; O'Callaghan P; Heindryckx F; Spillmann D; Larsson E; Le Jan S; Eriksson I; Gerwins P; Kjellén L; Kreuger J
J Biol Chem; 2013 Sep; 288(36):25956-25963. PubMed ID: 23884416
[TBL] [Abstract][Full Text] [Related]
6. The Reduction of PSMB4 in T24 and J82 Bladder Cancer Cells Inhibits the Angiogenesis and Migration of Endothelial Cells.
Lin YH; Chen TM; Tsai YL; Tsai WC; Wang HH; Chen Y; Wu ST
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791597
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.
Ashrafizadeh M; Hushmandi K; Hashemi M; Akbari ME; Kubatka P; Raei M; Koklesova L; Shahinozzaman M; Mohammadinejad R; Najafi M; Sethi G; Kumar AP; Zarrabi A
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784711
[TBL] [Abstract][Full Text] [Related]
8. CircRNA LOC729852 promotes bladder cancer progression by regulating macrophage polarization and recruitment via the miR-769-5p/IL-10 axis.
Dong C; Hui P; Wu Z; Li J; Man X
J Cell Mol Med; 2024 Apr; 28(7):e18225. PubMed ID: 38506082
[TBL] [Abstract][Full Text] [Related]
9. A Type 2 Deiodinase-Dependent Increase in
An X; Ogawa-Wong A; Carmody C; Ambrosio R; Cicatiello AG; Luongo C; Salvatore D; Handy DE; Larsen PR; Wajner SM; Dentice M; Zavacki AM
Thyroid; 2021 Jan; 31(1):115-127. PubMed ID: 32787533
[No Abstract] [Full Text] [Related]
10. The RNA-binding protein sorbin and SH3 domain-containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor.
Wang B; Fan X; Wang L; Wei X
Mol Carcinog; 2024 Jun; 63(6):1174-1187. PubMed ID: 38501385
[TBL] [Abstract][Full Text] [Related]
11. ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling.
Chen L; Xie X; Wang T; Xu L; Zhai Z; Wu H; Deng L; Lu Q; Chen Z; Yang X; Lu H; Chen YG; Luo S
Neuro Oncol; 2023 May; 25(5):871-885. PubMed ID: 36322624
[TBL] [Abstract][Full Text] [Related]
12. Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signaling.
Fleetwood F; Güler R; Gordon E; Ståhl S; Claesson-Welsh L; Löfblom J
Cell Mol Life Sci; 2016 Apr; 73(8):1671-83. PubMed ID: 26552422
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of microRNAs, long noncoding RNAs, and circular RNAs regulating lymphatic metastasis of bladder cancer.
Zengzhao W; Xuan L; Xiaohan M; Encun H; Jibing C; Hongjun G
Urol Oncol; 2024 Jan; 42(1):3-17. PubMed ID: 37989693
[TBL] [Abstract][Full Text] [Related]
14. Downregulated circRNA_CDKN1A promotes gallbladder cancer progression through activation of the NF-κB pathway.
Hu B; Yang H; Wang Y; Cao Y; Zhou R; Yang D
Cell Biochem Funct; 2024 Mar; 42(2):e3952. PubMed ID: 38343018
[TBL] [Abstract][Full Text] [Related]
15. N-myc Downstream-Regulated Gene 1 (NDRG1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).
Zhang X; Chen Q; Li Y; Chen H; Jiang Q; Hu Q
Biomed Res Int; 2022; 2022():3233004. PubMed ID: 35813230
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA CCT3 is a unique molecular marker in bladder cancer.
Luo L; Xie Q; Wu Y; Li P; Qin F; Liao D; Wang K
BMC Cancer; 2023 Oct; 23(1):977. PubMed ID: 37833621
[TBL] [Abstract][Full Text] [Related]
17. Targeting choroidal vascular dysfunction via inhibition of circRNA-FoxO1 for prevention and management of myopic pathology.
Li D; Liu C; Sun YN; Zhu CY; Xu SS; Shan K; Zhang SJ; Yan B; Lu Y
Mol Ther; 2021 Jul; 29(7):2268-2280. PubMed ID: 33647458
[TBL] [Abstract][Full Text] [Related]
18. Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs.
Shi X; Pang S; Zhou J; Yan G; Gao R; Wu H; Wang Z; Wei Y; Liu X; Tan W
Mol Cancer; 2024 Mar; 23(1):52. PubMed ID: 38461272
[TBL] [Abstract][Full Text] [Related]
19. circITGA7 Functions as an Oncogene by Sponging miR-198 and Upregulating FGFR1 Expression in Thyroid Cancer.
Li S; Yang J; Liu X; Guo R; Zhang R
Biomed Res Int; 2020; 2020():8084028. PubMed ID: 32685526
[TBL] [Abstract][Full Text] [Related]
20. MYLK and CALD1 as molecular targets in bladder cancer.
Jin H; Liu B; Guo X; Qiao X; Jiao W; Yang L; Song X; Wei Y; Jin T
Medicine (Baltimore); 2023 Nov; 102(47):e36302. PubMed ID: 38013282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
